Dovato (dolutegravir/lamivudine): Uses, Side Effects, Dosage & FAQs
Dovato is the Brand name for the combination of two medications, such as dolutegravir and lamivudine. The US Food And Drugs Administration (FDA) has approved the treatment of HIV infection based on two drugs and a Single tablet Regime (STR). It is used to control HIV infection. It helps reduce the amount of HIV in your body so that your immune system can function better. This reduces the likelihood of complications of HIV (for example, new infections, cancer) and improves the quality of life. The drug Dovato, marketed by GlaxoSmithKline (GSK), has been reported as a complete regimen for the treatment of HIV-1 infection in adult patients with no history of antiretroviral treatment and no known or suspected substitutions associated with resistance to either dolutegravir or lamivudine. Facts Generic: Dolutegravir and lamivudine Drug Class: Combination of antiretroviral drugs Dosage Form: Tablet Imprint : SV 137 Use: HIV-1 infection in adult...